Climate Change Data

Environmental Metrics

ESG Focus Areas

• Sustainable Access to Medicine
• Patient Outcomes and Contribution to Global Public Health
• Talent Management
• Employee Engagement
• Workplace Health and Safety
• Diversity and Inclusion
• Manufacturing and Distribution
• Supply Chain
• Regulatory Impact
• Climate Change and Energy
• Business Ethics

Environmental Achievements

• Increased recycling at Vega Baja, Puerto Rico site from 913 tons in 2020 to 985 tons in 2021 (85% of waste recycled)
• Recycled more than 2,400 mt of plastic waste across all India operations
• 10% reduction in GHG emissions at Vega Baja, Puerto Rico site (~4,280 mt CO2e)
• ~$500,000 saved on electricity costs at Vega Baja, Puerto Rico site in 2021 due to CHP system

Social Achievements

• Launched Semglee® (insulin glargine-yfgn) injection, the first interchangeable biosimilar product in the U.S.
• Expanded availability of Ogiviri® and Fulphilia® in South Africa, saving nearly $2 million USD
• Supplied more than 30,000 units of trastuzumab to the Philippines Department of Health for their Breast Cancer Medicines Access Program (BCMAP)
• Launched various mental health initiatives reaching 8 million people in 14 markets
• 98% of Viatris India employees vaccinated for COVID-19

Governance Achievements

• Established a solid foundation for future sustainability efforts, including company-wide goals in patient access, environment, and DE&I
• Continued to support colleagues during global restructuring initiative, providing severance pay, healthcare continuation, and outplacement services
• Implemented a common performance management process, with nearly 95% of employees completing evaluations
• Achieved 97% completion rate for Code of Business Conduct and Ethics training

Climate Goals & Targets

Environmental Challenges

• Ongoing COVID-19 pandemic and its impact on global supply chains
• Global health disparities and access to healthcare
• Increasing effects of climate change
• Drug shortages
• Global restructuring initiative

Mitigation Strategies

• Implemented social distancing measures, daily health assessments, and split shifts to protect employees
• Upholding high customer service levels via a reliable supply chain
• Developed a rapid response system to address supply chain disruptions
• Established company-wide goals to address ESG challenges
• Provided support to impacted employees during restructuring

Supply Chain Management

Supplier Audits: 612 GMP, 69 GCP, and 23 pharmacovigilance (PV) audits conducted in 2021

Responsible Procurement

• Supplier Code of Conduct
• EHS, labor, and ethics assessments
• Sustainability risk assessments based on PSCI principles

Climate-Related Risks & Opportunities

Physical Risks

• Extreme weather events

Transition Risks

• Regulatory changes
• Market shifts

Opportunities

• Increased use of renewable energy
• Energy efficiency projects

Reporting Standards

Frameworks Used: GRI Standards: Core level, SASB standards for Biotechnology & Pharmaceuticals, TCFD, UNGC

Certifications: ISO 14001, ISO 45001, ISO 50001, British Safety Council 5-star rating (four sites in India)

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• SDG 3 (Good Health and Well-being)
• SDG 5 (Gender Equality)
• SDG 6 (Clean Water and Sanitation)
• SDG 8 (Decent Work and Economic Growth)
• SDG 10 (Reduced Inequalities)
• SDG 12 (Responsible Consumption and Production)
• SDG 13 (Climate Action)
• SDG 17 (Partnerships for the Goals)

Viatris' initiatives contribute to these goals through access to medicine, sustainable operations, community engagement, and employee well-being programs

Sustainable Products & Innovation

• Semglee® (interchangeable biosimilar)
• CB12 mouthwash bottles made from 100% recycled plastic

Awards & Recognition

• Fortune’s Change the World list
• Newsweek’s America’s Most Responsible Companies list
• Forbes’ World’s Best Employers list

Environmental Metrics

ESG Focus Areas

• Access and Global Health
• Diversity, Equity and Inclusion (DEI)
• Environment

Environmental Achievements

• Science Based Target initiative (SBTi) independently assessed and approved near-term science-based greenhouse gas emissions reduction targets to cut scope 1 and 2 emissions by 42% by 2030 and scope 3 emissions by 25% by 2030.
• Reduced water withdrawal by almost 7% in 2022.
• Sent 35,700 metric tons of waste to waste-to-energy facilities for use as an alternative fuel source; 75% of this came from our API facilities located in India.

Social Achievements

• 89% participation in Viatris’ first-ever Voice Survey.
• Donated more than 450 million doses of medicines for humanitarian needs through our partners around the world.
• Donated a total of $1 million to aid in supporting access to healthcare, food security and water stewardship in communities around the world.

Governance Achievements

• Viatris’ Board of Directors oversees management’s efforts with respect to corporate environmental and social responsibility matters through its Risk Oversight Committee.
• Established Viatris’ Supplier Code of Conduct.
• Enhanced compliance training modules covering Anti-Corruption, Fair Competition and the Code of Business Conduct and Ethics.

Climate Goals & Targets

Environmental Challenges

• COVID-19 pandemic impacts on healthcare systems and access.
• Global inflation and economic uncertainty.
• War in Ukraine creating urgent needs and supply chain disruptions.
• Antimicrobial resistance (AMR).

Mitigation Strategies

• Provided widespread and cost-efficient access to remdesivir and molnupiravir.
• Maintained adequate stocks of needed medicines.
• Provided cost-of-living payment to more than 10,000 colleagues.
• Participated in AMR Industry Alliance (AMRIA) initiatives.
• Implemented AMRIA Common Antibiotic Manufacturing Standard.

Supply Chain Management

Supplier Audits: 777 GMP audits, 69 GCP audits, 13 pharmacovigilance (PV) audits

Responsible Procurement

• Supplier Code of Conduct
• PSCI principles
• Sustainable sourcing practices

Climate-Related Risks & Opportunities

Physical Risks

• Extreme weather events

Transition Risks

• Regulatory changes
• Market shifts

Opportunities

• Increased use of renewable energy
• Energy efficiency projects

Reporting Standards

Frameworks Used: GRI Standards, SASB standards for Biotechnology & Pharmaceuticals, TCFD, UNGC

Certifications: ISO 14001, ISO 45001, ISO 50001

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Goal 3 (Good Health and Well-being)
• Goal 6 (Clean Water and Sanitation)
• Goal 8 (Decent Work and Economic Growth)
• Goal 12 (Responsible Consumption and Production)
• Goal 13 (Climate Action)
• Goal 17 (Partnerships for the Goals)

Initiatives contributing to SDGs described throughout the report.

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Forbes’ World’s Best Employers
• Top Employer Institute awards
• Great Place to Work™
• Heart to Heart International’s Gary B. Morsch Humanitarian Award

Environmental Metrics

ESG Focus Areas

• Access and Global Health
• Our People
• Environment
• Community
• Governance and Ethical Practices

Environmental Achievements

• Named to USA Today’s inaugural list of America’s Climate Leaders 2023 for companies that have demonstrated the greatest reduction in emissions intensity
• 3.7% reduction of scope 1 and 2 emissions compared to 2020 baseline
• Thirteen sites achieved zero-waste landfill status in 2023

Social Achievements

• Supplied high-quality medicines to approximately 1 billion patients around the world
• More than 24,000 individuals have an NCD Academy account, representing approximately 60.5 million patients impacted to date.
• 97% of colleagues participated in DEI learning by the end of 2023
• Launched Viatris’ global wellbeing program for all colleagues

Governance Achievements

• Viatris is a signatory to the United Nations Global Compact (UNGC)
• The Global Sustainability function operates as a center of excellence within the Corporate Affairs leadership team.
• Completed our second full cycle of talent review and succession planning

Climate Goals & Targets

Environmental Challenges

• Growing impact of climate change on the environment and human health
• Global progress on SDGs is going slow, has stalled or in some areas reversed across many of the goal areas.
• Growing gap in supply and demand for healthcare workers
• Continued emergence of antimicrobial resistance (AMR)

Mitigation Strategies

• Implementing technologies, processes and systems to minimize environmental impact
• Investing in and engaging in HCP outreach and education
• Launched Elevate, our new wellbeing program for all colleagues
• Working with partners across regions to strengthen mental health outreach and care
• Compliance with AMRIA’s Antibiotic Manufacturing Standard

Supply Chain Management

Supplier Audits: 30 supplier assessments completed since 2022

Responsible Procurement

• Viatris’ Supplier Code of Conduct
• PSCI principles

Climate-Related Risks & Opportunities

Physical Risks

• Hurricanes
• Extreme heat
• Flooding

Transition Risks

• Regulatory changes
• Market shifts

Opportunities

• Increasing renewable energy usage
• Implementing energy-efficiency projects

Reporting Standards

Frameworks Used: GRI, SASB, TCFD, UNGC

Certifications: ISO 14001, ISO 50001, ISO 45001

Third-party Assurance: Third-party assurance for GHG emissions data in progress; 2022 CDP Climate Change and Water Security Programs were verified by an external party

UN Sustainable Development Goals

• 3
• 4
• 5
• 6
• 7
• 12
• 13
• 17

Viatris' initiatives contribute to these goals through its work in access to medicine, healthcare worker empowerment, environmental stewardship, community engagement, and responsible business practices.

Sustainable Products & Innovation

• Breyna™ Inhalation Aerosol

Awards & Recognition

• TIME’s World’s Best Companies 2023
• Forbes List of World’s Best Employers 2023
• USA Today’s America Climate Leader list 2023